TLS Advisors LLC

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 7, 2024), TLS Advisors LLC reported 19 stock positions worth $40.0 million. Its top holding was BHP Group Ltd.-Spon ADR (BHP) at 17.7% of the portfolio, followed by Rio Tinto PLC-Spon ADR (RIO, 17.0%) and Eqt (EQT, 14.0%). Compared with Q1 2024, it opened 4 new positions, added to 2 and reduced 1. The biggest buy was a new position in Nucor (NUE) and the biggest sale Ovid Therapeutics (OVID, shares −15%).

Most Recent 13F
Q2 2026
Location
MIAMI, FL
CIK
0001768824
Portfolio Value
$40.0M (Q2 2024)
SEC Filing
0001768824-24-000005 ↗ filed Aug 7, 2024

Holdings Value

0$10.0M$20.0M$30.0M$40.0M$50.0M Q1 2024: $43.0M Q1 2024 Q2 2024: $40.0M $40.0M Q2 2024 Q3 2024: $47.3M Q3 2024 Q4 2024: $43.7M Q4 2024 Q1 2025: $44.3M Q1 2025 Q2 2025: $32.0M Q2 2025 Q3 2025: $34.4M Q3 2025 Q4 2025: $31.1M Q4 2025 Q1 2026: $42.1M Q1 2026 Q2 2026: $34.0M Q2 2026

Holdings 19 stocks · $40.0M
BHP BHP Group Ltd.-Spon ADR 17.71% 123,960 $7.1M Add +10.7%
RIO Rio Tinto PLC-Spon ADR 17.01% 103,100 $6.8M No change
EQT Eqt Corp. 13.96% 150,800 $5.6M No change
META Meta Platforms Inc. Class A 13.36% 10,589 $5.3M No change
VALE Vale SA-SP ADR 11.30% 404,000 $4.5M Add +9.8%
XOMA Xoma Royalty Corporation filed as XOMA CORP DEL 7.14% 120,365 $2.9M No change
RRC Range Resources Corp. 4.02% 47,923 $1.6M No change
XENE Xenon Pharmaceuticals Inc. 3.22% 32,956 $1.3M No change
NUE Nucor Corp. 3.16% 8,000 $1.3M New
OABI Omniab Inc. 2.35% 250,185 $938K No change
OVID Ovid Therapeutics Inc. 2.17% 1,125,296 $866K Reduce -14.7%
HOV Hovnanian Enterprises-A 1.37% 3,872 $549K No change
WY Weyerhaeuser Co. 1.07% 15,000 $426K New
NBIS Nebius Group NV filed as YANDEX N V 0.74% 17,811 $294K No change
REGN Regeneron Pharmaceuticals 0.66% 250 $263K No change
EWS iShares MSCI Singapore ETF 0.65% 13,600 $261K No change
AEI Alset Inc. 0.05% 11,140 $18K New
ENZB Enzo Biochem Inc. 0.04% 13,616 $14K New
RVP Retractable Technologies Inc. 0.03% 12,152 $13K No change

Portfolio Sells Q1 2024 → Q2 2024
OVID Ovid Therapeutics Inc. Reduce -14.7% 2.17% −7.20

Portfolio Buys Q1 2024 → Q2 2024
NUE Nucor Corp. New 3.16% +3.16
BHP BHP Group Ltd.-Spon ADR Add +10.7% 17.71% +2.68
WY Weyerhaeuser Co. New 1.07% +1.07
VALE Vale SA-SP ADR Add +9.8% 11.30% +0.85
AEI Alset Inc. New 0.05% +0.05
ENZB Enzo Biochem Inc. New 0.04% +0.04

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 17$34.0MEQT, META, RIO, PICK, FISV
Q1 2026 16$42.1MEQT, RIO, META, PICK, XOMA
Q4 2025 16$31.1MXLP, RIO, PICK, EQT, SPLV
Q3 2025 19$34.4MEQT, META, RIO, PICK, XOMA
Q2 2025 13$32.0MEQT, META, RIO, PICK, XOMA
Q1 2025 15$44.3MEQT, PICK, RIO, META, VALE
Q4 2024Amended 17$43.7MBHP, EQT, META, RIO, VALE
Q3 2024 19$47.3MBHP, RIO, EQT, META, VALE
Q2 2024 19$40.0MBHP, RIO, EQT, META, VALE
Q1 2024 15$43.0MRIO, BHP, EQT, META, VALE